Side-by-side comparison

Compare investment strategies

NVDA and Eli Lilly with Short S&P and Beta Hedge vs Solid Companies Quality Stock Portfolio

At a glance

The headline numbers each source publishes, lined up. Hover a number for its exact definition.

These strategies report performance on different (OOS, Hypo). Live and composite results come from real accounts; out-of-sample, hypothetical and model results don't. Compare return and risk with care.

28.4%

—

53.6%Best

42.9%

31.4%

—

1.53Best

1.06

-25.3%Best

-34.8%

Each source uses its own scale

—

18(Heart Attack Index (Collective2))

Inception

2023-12-09

2024-06-02

Holdings

—

60%

67%Best

Growth of $10,000

Each line starts at $10,000 on the first date all of them share, using the strategy's own published history. Bases are labelled and never mixed within a line.

Solid Companies Quality Stock PortfolioHypoup 135.2%
S&P 500 ETFup 45.7%

No published history to chart: NVDA and Eli Lilly with Short S&P and Beta Hedge.

Every published figureShow 73 attributes

Each row is one exact variant (window and basis), so a value appears only where a source publishes it.

Classification

AI categories (Composer)

concentrated, daily rebalance, defensive overlay, healthcare, market-neutral, rsi filters, semiconductors, tactical, volatility-regime

—

Asset classes / instruments

equities

stocks

Leaderboard views (Collective2)

—

ira_account, popular

Market-relative

Alpha vs S&P 500, strategy life (hypothetical model account)

—

0.06

Alpha vs SPY, out-of-sample (out-of-sample)

0.21

—

Beta vs S&P 500, strategy life (hypothetical model account)

—

0.85

Beta vs SPY, out-of-sample (out-of-sample)

1.27

—

Correlation (R) vs SPY, out-of-sample (out-of-sample)

0.63

—

Correlation to S&P 500, strategy life (hypothetical model account)

—

0.43

Returns

Annual return compounded, strategy life (hypothetical model account)

—

42.90%

Annualized return since inception (Lighthorse, daily, hypothetical)

—

44.07%

Backtest length

3,790

—

Out-of-sample length

709

—

Return, 1 month (hypothetical model account)

—

0.53%

Return, 3 months (hypothetical model account)

—

5.72%

Return, 6 months (hypothetical model account)

—

9.70%

Return, backtest period (annualized) (backtest)

52.45%

—

Return, backtest period (cumulative) (backtest)

57k%

—

Return, last 365 days (Lighthorse, daily, hypothetical)

—

10.73%

Return, out-of-sample period (annualized) (out-of-sample)

53.59%

—

Return, out-of-sample period (cumulative) (out-of-sample)

235.02%

—

Return, trailing 1 day (out-of-sample)

0.15%

—

Return, trailing 1 month (out-of-sample)

3.87%

—

Return, trailing 1 week (out-of-sample)

0.59%

—

Return, trailing 1 year (backtest)

28.43%

—

Return, trailing 1 year (out-of-sample)

28.41%

—

Return, trailing 2 weeks (out-of-sample)

0.80%

—

Return, trailing 3 months (out-of-sample)

5.70%

—

SPY annualized return over the backtest window (backtest)

15.41%

—

Trading activity

Annualized turnover, backtest period (backtest)

7.58

—

Annualized turnover, out-of-sample period (out-of-sample)

9.24

—

Average leverage

—

0.74

Average position time

—

196,243

Daily win rate, backtest period (backtest)

54.38%

—

Daily win rate, out-of-sample period (out-of-sample)

56.70%

—

Maximum daily leverage

—

1.41

Number of trades

—

336

Percent of trades profitable

—

57.23%

Profit factor

—

2.77

Win:loss ratio

—

2.77

Backtest

Backtest final value (from $10,000)

$5.7M

—

Backtest regulatory fees

$3,365

—

Backtest slippage cost

$27k

—

Risk metrics

Calmar ratio, backtest period (backtest)

1.59

—

Calmar ratio, out-of-sample period (out-of-sample)

2.12

—

Maximum drawdown since inception (Lighthorse, daily, hypothetical)

—

-31.83%

Maximum drawdown, backtest period (backtest)

-32.99%

—

Maximum drawdown, last 365 days (Lighthorse, daily, hypothetical)

—

-31.70%

Maximum drawdown, out-of-sample period (out-of-sample)

-25.28%

—

Maximum drawdown, strategy life (hypothetical model account)

—

-34.80%

Sharpe ratio since inception (Lighthorse, daily, hypothetical)

—

1.02

Sharpe ratio, backtest period (backtest)

1.64

—

Sharpe ratio, last 365 days (Lighthorse, daily, hypothetical)

—

0.36

Sharpe ratio, out-of-sample period (out-of-sample)

1.53

—

Sharpe ratio, strategy life (hypothetical model account)

—

1.06

Sortino ratio, backtest period (backtest)

2.61

—

Sortino ratio, last 365 days (Lighthorse, daily, hypothetical)

—

0.51

Sortino ratio, out-of-sample period (out-of-sample)

2.33

—

Sortino ratio, strategy life (hypothetical model account)

—

1.49

Standard deviation, backtest period (backtest)

28.10%

—

Standard deviation, out-of-sample period (out-of-sample)

31.38%

—

Volatility since inception (Lighthorse, daily, hypothetical)

—

37.31%

Volatility, last 365 days (Lighthorse, daily, hypothetical)

—

43.84%

Quality

Community review status

ACTIVE

—

Holdings

Concentration (Herfindahl index, out-of-sample, as Composer reports it)

0.52

—

Risk score

Heart Attack Index (Collective2)

—

Construction

Logic complexity (node count)

—

Rebalance frequency

daily

—

Popularity

Remixes (copies)

—

Watchers

—

Identity

Strategy age

—

862

Cost & access

Subscription price per month

—

$59

Suggested minimum capital

—

$15k

Compare investment strategies

At a glance

Growth of $10,000

What they say: stated rules

What they hold

Do the holdings back the rules?

Costs, access & sources

Compare investment strategies

At a glance

Growth of $10,000

What they say: stated rules

What they hold

Do the holdings back the rules?

Costs, access & sources